Pathology

Thomas Haugen, PhD, MD

Portrait

Mailing Address

Office: 113 VA
Iowa City, IA 52242
Phone: +1 319 338 0581
Email: thomas-haugen@uiowa.edu

Web: Research Laboratory (Papillomavirus Infection and Carcinogenesis)

Education

BA, Biochemistry, University of California, Berkeley, 1971
PhD, Biochemistry, University of California, Davis, 1976
MD, Pathology, University of Iowa College of Medicine, 1983
Residency, Pathology, Department of Pathology, University of Iowa Hospitals and Clinics, 1989
Fellowship, Pathology (Microbiology), Department of Pathology, University of Iowa Hospitals and Clinics, 1990

Appointments

Primary: Pathology

Research Interests

Human Papillomavirus, Papillomavirus Infection and Carcinogenesis

Research Summary

Papillomaviruses induce benign epithelial proliferation (e.g., warts) of the skin and mucosa. Individual papilloma-virus types are associated with benign lesions whereas others are found in proliferative lesions with a low or even considerable malignant potential.

Mucosal human papillomaviruses (HPV) cause cervical cancer and are associated with a subset of head and neck cancers. In the infected cell, productive papillomavirus particles are derived from extrachromosomal viral plasmids. However, in many invasive HPV positive neoplasms, the HPV DNA is partially deleted and integrated into the cell genomic DNA. We have identified HPV-16 isolates that can establish persistent replication and "immortalize" primary human foreskin, cervical and tonsillar keratinocytes. Using primary keratinocytes and keratinocyte derived cell lines we have developed assays that allow us study human papilloma virus (HPV)-16 infection leading to persistence of replicating viral plasmid genomes. Our system allows us to dissect the individual viral factors required for this process. Studies are ongoing to determine how the regulation of viral gene expression controls viral replication.

Primary keratinocytes normally exhibit a limited life span in culture. Introduction of HPV-16 into these cells extends their ability to divide without limit. Many of the derived keratinocyte cultures exhibit no detectable chromosomal alterations and contain 10-40 copies of non-integrated plasmid HPV-16 DNA. Upon extended culture, cell lines may spontaneously arise that overgrow the culture and contain only integrated HPV-16 DNA and variable additional chromosomal abnormalities. These cell lines have many similarities to cells of squamous carcinomas that also contain integrated HPV. Studies are underway to determine the role these genetic alterations play in altered cell growth and other acquired phenotypes in these cell lines. These cell lines provide a useful model system for the study of papillomavirus induced carcinogenesis.

Publications

  • Rubenstein, L, Smith, E, Pawlita, M, Haugen, T, Hamšíková, E, Turek, L. Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer 6:9, 2011. [PubMed]
  • Lace, M, Anson, J, Klussmann, J, Wang, D, Smith, E, Haugen, T, Turek, L. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J Virol 85(4):1645-54, 2011. [PubMed]
  • Kreiter, C, Haugen, T, Leaven, T, Goerdt, C, Rosenthal, N, McGaghie, W, Dee, F. A report on the piloting of a novel computer-based medical case simulation for teaching and formative assessment of diagnostic laboratory testing. Med Educ Online 16:null, 2011. [PubMed]
  • Smith, E, Rubenstein, L, Haugen, T, Hamsikova, E, Turek, L. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control 21(9):1369-78, 2010. [PubMed]
  • Smith, E, Parker, M, Rubenstein, L, Haugen, T, Hamsikova, E, Turek, L. Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol 2010:326369, 2010. [PubMed]
  • Smith, E, Rubenstein, L, Hoffman, H, Haugen, T, Turek, L. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 5:4, 2010. [PubMed]
  • Lace, M, Anson, J, Haugen, T, Turek, L. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes. Virology 399(2):270-9, 2010. [PubMed]
  • Smith, E, Pawlita, M, Rubenstein, L, Haugen, T, Hamsikova, E, Turek, L. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer 127(1):111-7, 2010. [PubMed]
  • Lace, M, Yamakawa, Y, Ushikai, M, Anson, J, Haugen, T, Turek, L. Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site. J Gen Virol 90(Pt 10):2402-12, 2009. [PubMed]
  • Lace, M, Isacson, C, Anson, J, Lörincz, A, Wilczynski, S, Haugen, T, Turek, L. Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. J Virol 83(15):7457-66, 2009. [PubMed]